. 2019 Feb 14;14(2):149–155. doi: 10.1016/j.jtumed.2019.01.004

Table 2.

Average liver damage.

Treatment	The average liver damage (%)
Treatment	IC	C	P	VD	N
Normal	18.03 ± 0.32^a	26 ± 0.2^a	0 ± 0^a	50.03 ± 0.06^a	0 ± 0^a
NC	50.1 ± 0.25^b	50.13 ± 0.06^b	83.17 ± 0.49^f	85.47 ± 0.25^d	78.27 ± 0.12^d
PC	50.03 ± 0.16^b	50.1 ± 0.36^b	50.17 ± 0.35^c	50.13 ± 0.12^ab	50.43 ± 0.31^b
T1	50.23 ± 0.25^b	50.23 ± 0.25^b	50.37 ± 0.06^c	50.37 ± 0.15^b	50.47 ± 0.31^b
T2	50.1 ± 0.17^b	50.07 ± 0.16^b	62.13 ± 0.15^d	50.4 ± 0.1^b	66.5 ± 0.3^c
T3	50 ± 0.25^b	50.07 ± 0.42^b	71.1 ± 0.17^e	69.13 ± 0.15^c	66.4 ± 0.3^c
T4	50.03 ± 0.06^b	50.03 ± 0.21^b	45.17 ± 0.29^b	50.2 ± 0.23^ab	50.4 ± 0.2^b

NC, negative control; PC, positive control; T1, dosage of 2.5 mg/kg; T2, dosage of 5 mg/kg; T3, dosage of 7.5 mg/kg; T4, dosage of 10 mg/kg; IC, inflammatory cells; C, congestion; P, pyknosis; VD, vacuole degeneration; N, necrosis. Values with similar superscripts within a column are not significantly different at 0.05 probably level.